Ameritas Investment Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Ameritas Investment Partners’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50	Closed	-$7K	–	3348
2022 Q1	$7K	Hold	50	–	–	﹤0.01%	2914
2021 Q4	$9K	Hold	50	–	–	﹤0.01%	2944
2021 Q3	$25K	Hold	50	–	–	﹤0.01%	2587
2021 Q2	$25K	Buy	+50	New	+$26.9K	﹤0.01%	2638
2019 Q2	–	Sell	-24	Closed	-$4K	–	3143
2019 Q1	$4K	Hold	24	–	–	﹤0.01%	2898
2018 Q4	$3K	Hold	24	–	–	﹤0.01%	2926
2018 Q3	$4K	Hold	24	–	–	﹤0.01%	2974
2018 Q2	$16K	Buy	+24	New	+$18K	﹤0.01%	2639
2017 Q2	–	Sell	-11	Closed	-$3K	–	3076
2017 Q1	$3K	Buy	+11	New	+$2.96K	﹤0.01%	2911

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameritas Investment Partners's AMPE Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 50 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in AMPE in Q1 2017 and held it in 9 quarters. The position peaked at $25K in Q3 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

Ameritas Investment Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 50 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $7K.
Ameritas Investment Partners first reported a position in Ampio Pharmaceuticals Inc. in Q1 2017 and held it in 9 quarters.
Ameritas Investment Partners's Ampio Pharmaceuticals Inc. position peaked at $25K in Q3 2021.
111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.